$1.06 Earnings Per Share Expected for AFLAC Incorporated (NYSE:AFL) This Quarter

Wall Street brokerages expect that AFLAC Incorporated (NYSE:AFL) will report $1.06 earnings per share (EPS) for the current fiscal quarter, according to Zacks Investment Research. Three analysts have issued estimates for AFLAC’s earnings, with estimates ranging from $1.03 to $1.09. AFLAC posted earnings of $1.03 per share in the same quarter last year, which would indicate a positive year over year growth rate of 2.9%. The business is scheduled to announce its next earnings results on Wednesday, October 23rd.

According to Zacks, analysts expect that AFLAC will report full year earnings of $4.34 per share for the current year, with EPS estimates ranging from $4.30 to $4.40. For the next financial year, analysts expect that the firm will post earnings of $4.49 per share, with EPS estimates ranging from $4.45 to $4.52. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of sell-side research firms that follow AFLAC.

AFLAC (NYSE:AFL) last released its quarterly earnings data on Thursday, July 25th. The financial services provider reported $1.13 earnings per share for the quarter, topping the consensus estimate of $1.07 by $0.06. AFLAC had a return on equity of 12.94% and a net margin of 14.24%. The business had revenue of $5.51 billion during the quarter, compared to analysts’ expectations of $5.46 billion. During the same quarter last year, the business posted $1.07 EPS. The business’s revenue was down 1.4% on a year-over-year basis.

AFL has been the subject of a number of research analyst reports. ValuEngine cut AFLAC from a “sell” rating to a “strong sell” rating in a research note on Thursday, August 1st. Barclays raised their target price on AFLAC from $45.00 to $53.00 and gave the company an “equal weight” rating in a research note on Wednesday, May 22nd. Zacks Investment Research upgraded AFLAC from a “hold” rating to a “buy” rating and set a $55.00 price objective for the company in a research note on Tuesday, April 30th. Evercore ISI cut AFLAC from an “in-line” rating to an “underperform” rating and set a $56.57 price objective for the company. in a research note on Tuesday, July 16th. Finally, UBS Group lowered their price objective on AFLAC from $50.00 to $49.00 and set a “neutral” rating for the company in a research note on Tuesday, April 30th. Two research analysts have rated the stock with a sell rating, six have given a hold rating and two have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus target price of $52.62.

Shares of AFL traded up $0.58 on Friday, reaching $52.65. The stock had a trading volume of 2,554,700 shares, compared to its average volume of 3,478,103. The firm has a market capitalization of $37.97 billion, a price-to-earnings ratio of 12.66, a price-to-earnings-growth ratio of 2.85 and a beta of 0.71. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.04 and a current ratio of 0.04. The company has a 50-day simple moving average of $54.47 and a 200-day simple moving average of $51.52. AFLAC has a 12-month low of $41.45 and a 12-month high of $57.18.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 3rd. Shareholders of record on Wednesday, August 21st will be issued a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a dividend yield of 2.05%. The ex-dividend date of this dividend is Tuesday, August 20th. AFLAC’s payout ratio is 25.96%.

In related news, Director Barbara K. Rimer sold 4,728 shares of AFLAC stock in a transaction on Friday, July 26th. The stock was sold at an average price of $53.74, for a total transaction of $254,082.72. Following the transaction, the director now directly owns 32,448 shares in the company, valued at $1,743,755.52. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider June P. Howard sold 4,000 shares of AFLAC stock in a transaction on Friday, August 2nd. The shares were sold at an average price of $52.35, for a total value of $209,400.00. Following the transaction, the insider now owns 64,591 shares in the company, valued at $3,381,338.85. The disclosure for this sale can be found here. In the last three months, insiders sold 85,980 shares of company stock valued at $4,500,870. Corporate insiders own 1.30% of the company’s stock.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. lifted its position in shares of AFLAC by 0.8% in the second quarter. Vanguard Group Inc. now owns 68,140,817 shares of the financial services provider’s stock worth $3,734,798,000 after buying an additional 557,750 shares in the last quarter. BlackRock Inc. increased its stake in AFLAC by 1.6% during the second quarter. BlackRock Inc. now owns 53,864,475 shares of the financial services provider’s stock worth $2,952,313,000 after acquiring an additional 834,790 shares during the last quarter. Wells Fargo & Company MN increased its stake in AFLAC by 1.6% during the second quarter. Wells Fargo & Company MN now owns 15,382,748 shares of the financial services provider’s stock worth $843,128,000 after acquiring an additional 240,111 shares during the last quarter. FMR LLC increased its stake in AFLAC by 2.8% during the first quarter. FMR LLC now owns 11,409,334 shares of the financial services provider’s stock worth $570,466,000 after acquiring an additional 307,940 shares during the last quarter. Finally, Geode Capital Management LLC increased its stake in AFLAC by 7.5% during the fourth quarter. Geode Capital Management LLC now owns 10,367,524 shares of the financial services provider’s stock worth $471,555,000 after acquiring an additional 724,613 shares during the last quarter. Institutional investors own 66.51% of the company’s stock.

AFLAC Company Profile

Aflac Incorporated, through its subsidiaries, provides voluntary supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers voluntary supplemental insurance products, including cancer plans, general medical indemnity plans, medical/sickness riders, care plans, living benefit life plans, ordinary life insurance plans, and annuities in Japan.

Featured Article: What strategies should day traders use to execute a trade?

Get a free copy of the Zacks research report on AFLAC (AFL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for AFLAC (NYSE:AFL)

Receive News & Ratings for AFLAC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AFLAC and related companies with MarketBeat.com's FREE daily email newsletter.